Log inSign up
Pharma-Marketing.comPharma-Marketing.com
  • Industry
  • Digital Health & AI
  • Channels
  • People
  • Agencies
  • Glossary
Log inSign up
  • Terms of Service
  • Privacy Policy
  • Cookie settings
  • Imprint
Pharma-Marketing.com

Copyright 2025 Pharma-Marketing.com.
All rights reserved.

We use AI tools in the creation of certain content.

Pharma Marketing

Data-privacy settings

We use cookies to improve our website and services. They help us understand how visitors use our website. Some cookies are required for the website to function. These are marked as “essential” in the details.

AcceptEssential cookie
NameData-privacy settings
ProviderPharma-Marketing.com
PurposeStores these privacy settings in your browser.
Privacy policyPrivacy policy
Cookiespm_data_privacy
Cookie expiration180 days
Accept
NameGoogle Analytics
ProviderGoogle LLC
PurposeCookies by Google are used for website analytics. Generates statistical data on how the visitor uses the website.
Privacy policyPrivacy policy
Cookies_ga, _gat, _gid
Cookie expiration2 Years
Accept
NameGoogle Ads
ProviderGoogle LLC
PurposeCookies by Google Ads are used for advertising and targeting purpose.
Privacy policyPrivacy policy
Cookies__gsas, __gpi, __gpi_optout, NID, DSID, test_cookie, id, __gads
Cookie expiration2 Years
Accept
NameFacebook
ProviderFacebook Inc.
PurposeCookies by Facebook are used for advertising and marketing activities. Generates statistical data on how the visitor uses the website.
Privacy policyPrivacy policy
Cookies_fbp, fr
Cookie expiration2 Years
Accept
NameMicrosoft Clarity
ProviderMicrosoft Corporation
PurposeCookies by Microsoft Clarity are used for website analytics, heatmaps, and session recordings. They help us understand how visitors interact with our website so we can improve usability and performance.
Privacy policyPrivacy policy
Cookies_clck, _clsk, CLID, ANONCHK, MR, MUID, SM
Cookie expirationUp to 1 Year
Image: Deutsche Herzstiftung

Tuesday, May 12, 2026

German Heart Foundation appoints Friso Janßen as CEO

The German Heart Foundation (Deutsche Herzstiftung e.V.) has appointed Friso Janßen as its new chief executive, effective 4 May 2026. He succeeds Martin Vestweber, who is retiring after more than two decades leading the nationwide patient organisation. Vestweber was also closely involved with the German Foundation for Heart Research (Deutsche Stiftung für Herzforschung, DSHF), co-founded in 1988.

Leadership transition after more than two decades

During Vestweber’s tenure, the organisation expanded services aimed at supporting people living with cardiovascular disease and increased its research funding. For context, the foundation reports around 110,000 members, research funding volume of EUR 6.7 million and income of EUR 21 million in 2025, describing its financial position as stable.

Background of the new CEO

Janßen, 41, is a trained nurse and holds a degree in health and nursing management. His career includes leadership roles in elderly care as well as management and regional sales positions in healthcare companies. In his new role, he aims to further develop the organisation strategically and strengthen its public visibility.

Focus areas: prevention, patient-relevant topics and research

According to the foundation, Janßen intends to put greater emphasis on prevention and on topics that resonate with patients’ everyday lives. Planned activities for 2026 include a focus on physical activity and initiatives addressing atrial fibrillation. Atrial fibrillation is set to be highlighted during the nationwide “Heart Weeks” in November, and the foundation also plans a dedicated research funding programme of EUR 1 million for this topic.

As broader context, the foundation notes that cardiovascular diseases remain the leading cause of death in Germany, with around 340,000 deaths per year, and the most common reason for hospital admissions.

Communication, digital channels and partnerships

Janßen sees additional reach through digital communication, including the use of new technologies such as AI, with an emphasis on responsible application. The foundation also stresses the continued importance of combining print and digital formats alongside direct personal outreach.

Partnerships with medical societies and other stakeholders remain a core element of the foundation’s work, including collaborations linked to the German Heart Report and joint initiatives with organisations such as the Association of Office-based Cardiologists (BNK) and the Björn Steiger Foundation (HERZSICHER). Janßen will be supported in management by deputy CEO Benjamin Schmitt, who had led operations on an interim basis since the beginning of the year.

Note: This article is based on information provided by the German Heart Foundation.

Advertisement

Only a few physicians log in to your website?

Advertisement

A login that sets a new standard for authenticating HCPs and equips your marketing team with everything they need to successfully promote Rx-products. Learn more on DocID.pro


Stay up to date!

Subscribe to our free Pharma-Marketing-Newsletter.


A Partner For Successful Marketing in Pharma & Healthcare

Advertisement

8awake, the specialized agency for pharma and healthcare marketing, supports you with the successful development and execution of winning campaign activities in healthcare.

Leading providers in pharma and healthcare marketing

Sponsored
  • MINTT Digital
  • 8awake
  • MINTT Digital

  • 8awake

    The leading Healthcare & Pharma-Marketing-Agency

Looking for a new partner in pharma and healthcare marketing?

Visit our agency finder